US Pre-Market SEC Filings Roundup — February 12, 2026

13-02-2026

Lendway, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-014713), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative details were provided in the filing description. This appears to be a standard earnings-related disclosure without detailed performance data.

13-02-2026

Moderna, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001682852-26-000015), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators were mentioned.

• ·AccNo: 0001682852-26-000015
• ·Sector: not specified

13-02-2026

13-02-2026

Sensient Technologies Corp filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases, but specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided information. No positive or negative performance indicators are detailed.

13-02-2026

AMC Entertainment Holdings, Inc. filed an 8-K on 2026-02-13 under Item 1.01 disclosing entry into a Material Definitive Agreement and under Item 9.01 providing Financial Statements and Exhibits. No specific details, transaction values, financial metrics, parties involved, or impacts are disclosed in the provided filing summary. No quantitative data or period-over-period comparisons are mentioned.

13-02-2026

The company filed an 8-K on February 13, 2026, under Item 8.01 Other Events, categorized as a General Filing with Accession Number 0001628280-26-007887 and file size of 150 KB. No specific details regarding the nature of the event, financial metrics, transactions, or impacts were disclosed in the filing information provided. No positive, negative, or flat performance metrics were mentioned.

13-02-2026

Haymaker Acquisition Corp. 4 filed an SEC document on February 13, 2026 (AccNo: 0001104659-26-014575, size 13 MB) related to a Merger/Acquisition event. No specific details on deal structure, parties involved beyond the filer, valuation, consideration, strategic rationale, regulatory pathway, shareholder impact, or market implications are explicitly stated or disclosed in the provided metadata. Critical transaction terms, financial metrics, and quantitative data are entirely absent.

• ·Filing Accession Number: 0001104659-26-014575
• ·Filing Size: 13 MB
• ·Sector: not specified

13-02-2026

Carlyle Secured Lending, Inc. filed an 8-K on February 13, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, financial metrics, transaction values, or performance changes disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance revisions are mentioned.

• ·AccNo: 0001544206-26-000006
• ·File size: 190 KB
• ·Critical missing information: Full content of Regulation FD disclosure, exhibit details, any financial data, transaction specifics, or scheduled events - affects analysis quality

13-02-2026

Marcus & Millichap, Inc. filed an 8-K on February 13, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

13-02-2026

Vyome Holdings, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015795, Size: 33 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are explicitly stated.

13-02-2026

Sound Financial Bancorp, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with limited transparency on content.

13-02-2026

W. P. Carey Inc. filed a Form 8-K on 2026-02-13 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction values, financial metrics, or impacts disclosed in the provided information. No positive or negative metrics are mentioned.

13-02-2026

ALLIANCE ENTERTAINMENT HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006492), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, position, appointment or resignation status, reasons, and timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

13-02-2026

Hyperscale Data, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001214659-26-001643, Size: 286 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, financial metrics, transactions, or other quantitative data are provided in the filing summary. This is a multi-item voluntary disclosure with no mentioned positive or negative metrics.

13-02-2026

Nektar Therapeutics filed a Form 8-K on 2026-02-13 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on a material agreement and additional events, with exhibits attached. No financial metrics, transaction details, positive or negative impacts, or quantitative data are disclosed.

13-02-2026

Advance Auto Parts Inc filed an 8-K on February 13, 2026, reporting under Item 2.02 results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing summary. No period-over-period comparisons, positive or negative changes, or quantitative data are available.

13-02-2026

AZZ INC filed an 8-K on February 13, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, period-over-period comparisons, or quantitative data are disclosed in the filing summary. The disclosure appears informational with attached exhibits, but content details are not provided.

13-02-2026

SunHydrogen, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015747, Size: 380 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or quantitative data provided.

13-02-2026

News Corp filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are provided.

13-02-2026

Atmus Filtration Technologies Inc. filed an 8-K on 2026-02-13 under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, positive or negative performance indicators, or other quantitative details are mentioned in the filing. Sector is not specified.

• ·AccNo: 0001921963-26-000012
• ·File Size: 492 KB

13-02-2026

Rithm Property Trust Inc. filed an 8-K on February 13, 2026, under Item 2.02 reporting Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance are disclosed in the provided filing details. This is an informational disclosure of financial results with exhibits attached.

13-02-2026

Nukkleus Inc. filed an 8-K on February 13, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. No positive or negative metrics are mentioned.

13-02-2026

Wendy's Co filed a Form 8-K on February 13, 2026 (AccNo: 0001193125-26-049816), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits, but specific revenue, earnings, margins, or other metrics are NOT_DISCLOSED in the provided information. No period-over-period comparisons, guidance, or other quantitative details are available.

13-02-2026

Essent Group Ltd. filed a Form 8-K on 2026-02-13 (AccNo: 0001448893-26-000003, Size: 1 MB) disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item earnings-related filing with no specific quantitative financial metrics, period-over-period changes, or performance details provided in the filing description. No positive or negative metrics are disclosed.

• ·AccNo: 0001448893-26-000003
• ·Filing size: 1 MB
• ·Sector: NOT_DISCLOSED

13-02-2026

Immunic, Inc. filed a Form 8-K on 2026-02-13 disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, share counts, or financial metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative data for impact assessment.

13-02-2026

Enbridge Inc filed an 8-K on February 13, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, transaction details, or scheduled events are mentioned.

13-02-2026

DraftKings Inc. filed a Form 8-K on February 13, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no detailed operational results available.

13-02-2026

Cooper-Standard Holdings Inc. filed an 8-K on 2026-02-13 under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing focused on financial results announcement. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.

13-02-2026

13-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 13, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material non-public information with attached exhibits.

13-02-2026

Tri Pointe Homes, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific quantitative details, transaction sizes, financial impacts, or directional metrics disclosed. No positive or negative performance metrics are provided.

13-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-13 under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are disclosed in the provided information. This is a multi-item mandatory filing likely made timely on the event date.

13-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. This appears to be a standard earnings-related disclosure with exhibits attached.

13-02-2026

Bloomin' Brands, Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer's name, position, reason for change, or timing are disclosed.

13-02-2026

Strive, Inc. filed a Form 8-K on February 13, 2026, under Item 8.01 Other Events, indicating a material event not covered by other specific 8-K items. No details on the core event, financial metrics, transaction values, or quantitative data were explicitly stated in the provided filing information. No positive or negative metrics were disclosed.

13-02-2026

Sonic Automotive Inc filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-007898) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed. This is a standard governance filing with no financial metrics, performance data, or scheduled events mentioned.

13-02-2026

LCI Industries filed an 8-K on February 13, 2026 (AccNo: 0000763744-26-000004, size 705 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

• ·Event date: February 13, 2026
• ·Source: us_sec
• ·Sector: not specified

13-02-2026

Evommune, Inc. filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), alongside Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). While the material agreement signals potential strategic advancement, the equity sales raise dilution concerns. No specific transaction values, terms, financial impacts, or quantitative details are disclosed.

13-02-2026

AtlasClear Holdings, Inc. filed an 8-K on February 13, 2026, under Item 2.02 to disclose results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific financial metrics, performance comparisons, guidance, or quantitative details are disclosed in the filing summary.

13-02-2026

GENCO SHIPPING & TRADING LTD filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, names, reasons, or timing were disclosed.

13-02-2026

HCW Biologics Inc. filed an 8-K on February 13, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01 and providing Financial Statements and Exhibits under Item 9.01. No details on the agreement's parties, terms, value, strategic rationale, or financial impacts are mentioned. This is a multi-item mandatory filing with no quantitative metrics, positive or negative changes, or performance comparisons provided.

13-02-2026

ASTROTECH Corp filed an 8-K on February 13, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing summary. This represents a standard voluntary disclosure of financial results without directional performance indicators.

13-02-2026

Citius Oncology, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-015894), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results.

13-02-2026

PCS Edventures!, Inc. filed a Form 8-K on February 13, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material nonpublic information with attached exhibits. No quantitative financial metrics, transactions, period-over-period changes, positive or negative performance indicators, or other specific details are disclosed.

13-02-2026

Royal Caribbean Cruises Ltd filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-014730), reporting under Item 1.01 entry into a material definitive agreement and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This appears to be a multi-item mandatory filing with limited public summary information available.

• ·Filing size: 482 KB
• ·Sector: not specified

13-02-2026

LAS VEGAS SANDS CORP filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. Sector is not specified.

13-02-2026

Citius Pharmaceuticals, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-015895), disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 2.02 results of operations and financial condition. Item 9.01 references financial statements and exhibits. This multi-item filing highlights a material compliance failure with exchange listing requirements, with no specific financial metrics or performance details provided.

• ·Multi-item 8-K filing (Items 2.02, 3.01, 9.01)
• ·Event date aligns with filing date: 2026-02-13

13-02-2026

Visa Inc. filed an 8-K on February 13, 2026, under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure likely sharing previously provided material nonpublic information publicly. No financial metrics, transactions, events, or other quantitative details are explicitly stated in the filing information provided.